Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Hexacarbon neurotoxicity

Journal Article · · Neurobehav. Toxicol. Teratol.; (United States)
OSTI ID:5025163
The neurotoxicity of hexacarbon solvents has become apparent only recently, but an extensive literature has already developed as a result of the clinical and epidemiological implications of the human disease, and the advantages of small animal models of hexacarbon neurotoxicity in investigation of experimental neuropathies. This review selectively summarizes the literature, focusing on clinical manifestations and pathological alterations in the peripheral nerves. The clinical manifestations are dominated by a distal, symmetrical, and sensorimotor polyneuropathy. Pathological changes include distal axonal degeneration and formation of neurofilament-filled axonal swellings in early or moderately severe exposure. A late manifestation in severely affected experimental animals is recurrent demyelination and remyelination.
Research Organization:
Johns Hopkins Univ. School of Medicine, Baltimore, MD
OSTI ID:
5025163
Journal Information:
Neurobehav. Toxicol. Teratol.; (United States), Journal Name: Neurobehav. Toxicol. Teratol.; (United States) Vol. 3:4; ISSN NTOTD
Country of Publication:
United States
Language:
English